{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:37:41Z","timestamp":1791499061415,"version":"4.3.4"},"reference-count":22,"publisher":"American Diabetes Association","issue":"7","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":3729,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,7,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Insulin recruits muscle microvasculature, thereby increasing endothelial exchange surface area. Free fatty acids (FFAs) cause insulin resistance by activating inhibitor of \u03baB kinase \u03b2. Elevating plasma FFAs impairs insulin\u2019s microvascular and metabolic actions in vivo. Whether salsalate, an anti-inflammatory agent, prevents FFA-induced microvascular and\/or metabolic insulin resistance in humans is unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Eleven healthy, young adults were studied three times in random order. After an overnight fast, on two occasions each subject received a 5-h systemic infusion of Intralipid \u00b1 salsalate pretreatment (50 mg\/kg\/day for 4 days). On the third occasion, saline replaced Intralipid. A 1 mU\/kg\/min euglycemic insulin clamp was superimposed over the last 2-h of each study. Skeletal and cardiac muscle microvascular blood volume (MBV), microvascular flow velocity (MFV), and microvascular blood flow (MBF) were determined before and after insulin infusion. Whole body glucose disposal rates were calculated from glucose infusion rates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Insulin significantly increased skeletal and cardiac muscle MBV and MBF without affecting MFV. Lipid infusion abolished insulin-mediated microvascular recruitment in both skeletal and cardiac muscle and lowered insulin-stimulated whole body glucose disposal (P &amp;lt; 0.001). Salsalate treatment rescued insulin\u2019s actions to recruit muscle microvasculature and improved insulin-stimulated whole body glucose disposal in the presence of high plasma FFAs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>High plasma concentrations of FFAs cause both microvascular and metabolic insulin resistance, which can be prevented or attenuated by salsalate treatment. Our data suggest that treatments aimed at inhibition of inflammatory response might help alleviate vascular insulin resistance and improve metabolic control in patients with diabetes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc10-2345","type":"journal-article","created":{"date-parts":[[2011,5,27]],"date-time":"2011-05-27T00:47:35Z","timestamp":1306457255000},"page":"1634-1638","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":39,"title":["Salsalate Attenuates Free Fatty Acid\u2013Induced Microvascular and Metabolic Insulin Resistance in Humans"],"prefix":"10.2337","volume":"34","author":[{"given":"Weidong","family":"Chai","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, and the General Clinical Research Center, University of Virginia Health System, Charlottesville, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, and the General Clinical Research Center, University of Virginia Health System, Charlottesville, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A.","family":"Jahn","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, and the General Clinical Research Center, University of Virginia Health System, Charlottesville, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale E.","family":"Fowler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, and the General Clinical Research Center, University of Virginia Health System, Charlottesville, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene J.","family":"Barrett","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, and the General Clinical Research Center, University of Virginia Health System, Charlottesville, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, and the General Clinical Research Center, University of Virginia Health System, Charlottesville, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2011,6,17]]},"reference":[{"key":"2022031302394154000_B1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.ATV.0000160549.60980.a8","article-title":"Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta","volume":"25","author":"Kim","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031302394154000_B2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-\u03b2 links inflammation to obesity-induced insulin resistance","volume":"11","author":"Arkan","year":"2005","journal-title":"Nat Med"},{"key":"2022031302394154000_B3","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J Clin Invest"},{"key":"2022031302394154000_B4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI11559","article-title":"Prevention of fat-induced insulin resistance by salicylate","volume":"108","author":"Kim","year":"2001","journal-title":"J Clin Invest"},{"key":"2022031302394154000_B5","doi-asserted-by":"crossref","first-page":"E1250","DOI":"10.1152\/ajpendo.00451.2007","article-title":"Insulin at physiological concentrations increases microvascular perfusion in human myocardium","volume":"293","author":"Liu","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031302394154000_B6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1210\/jc.2010-1174","article-title":"Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans","volume":"96","author":"Liu","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031302394154000_B7","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1210\/jc.2009-0027","article-title":"Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature","volume":"94","author":"Liu","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031302394154000_B8","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s00125-009-1313-z","article-title":"The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action","volume":"52","author":"Barrett","year":"2009","journal-title":"Diabetologia"},{"key":"2022031302394154000_B9","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.2337\/diabetes.51.4.1138","article-title":"Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo","volume":"51","author":"Clerk","year":"2002","journal-title":"Diabetes"},{"key":"2022031302394154000_B10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(\u03ba)B kinase-\u03b2","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"key":"2022031302394154000_B11","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s00125-009-1498-1","article-title":"Aspirin attenuates insulin resistance in muscle of diet-induced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of IRbeta\/IRS-1 and Akt","volume":"52","author":"Carvalho-Filho","year":"2009","journal-title":"Diabetologia"},{"key":"2022031302394154000_B12","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1061620","article-title":"Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta","volume":"293","author":"Yuan","year":"2001","journal-title":"Science"},{"key":"2022031302394154000_B13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2337\/dc07-1338","article-title":"Salsalate improves glycemia and inflammatory parameters in obese young adults","volume":"31","author":"Fleischman","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031302394154000_B14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00125-008-1239-x","article-title":"The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study","volume":"52","author":"Koska","year":"2009","journal-title":"Diabetologia"},{"key":"2022031302394154000_B15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-152-6-201003160-00004","article-title":"The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial","volume":"152","author":"Goldfine","year":"2010","journal-title":"Ann Intern Med"},{"key":"2022031302394154000_B16","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.2337\/diabetes.52.12.2882","article-title":"Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects","volume":"52","author":"Tripathy","year":"2003","journal-title":"Diabetes"},{"key":"2022031302394154000_B17","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.2337\/diabetes.49.7.1231","article-title":"Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production","volume":"49","author":"Steinberg","year":"2000","journal-title":"Diabetes"},{"key":"2022031302394154000_B18","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1172\/JCI119636","article-title":"Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation","volume":"100","author":"Steinberg","year":"1997","journal-title":"J Clin Invest"},{"key":"2022031302394154000_B19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI5001","article-title":"Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity","volume":"103","author":"Dresner","year":"1999","journal-title":"J Clin Invest"},{"key":"2022031302394154000_B20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0026-0495(00)91039-4","article-title":"Effect of insulin on human aortic endothelial nitric oxide synthase","volume":"49","author":"Aljada","year":"2000","journal-title":"Metabolism"},{"key":"2022031302394154000_B21","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/diab.46.6.994","article-title":"Mechanisms of the kinetic defect in insulin action in obesity and NIDDM","volume":"46","author":"Nolan","year":"1997","journal-title":"Diabetes"},{"key":"2022031302394154000_B22","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1210\/jc.2007-1212","article-title":"Salicylates increase insulin secretion in healthy obese subjects","volume":"93","author":"Fern\u00e1ndez-Real","year":"2008","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/34\/7\/1634\/610510\/1634.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/34\/7\/1634\/610510\/1634.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T06:56:22Z","timestamp":1647154582000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/34\/7\/1634\/38606\/Salsalate-Attenuates-Free-Fatty-Acid-Induced"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,17]]},"references-count":22,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2011,6,17]]},"published-print":{"date-parts":[[2011,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc10-2345","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,17]]}}}